Nuzzo, Silvia (2018) Selection of aptamers targeting a hypoxia marker: Carbonic Anhydrase-IX (CA-IX). [Tesi di dottorato]
Anteprima |
Testo
Silvia_Nuzzo_XXX_ciclo_Doctorate_in_Molecular_Medicine_and_Medical_Biotechnology_short_version.pdf Download (932kB) | Anteprima |
Anteprima |
Testo
Silvia_Nuzzo_XXX_ciclo_Doctorate_in_Molecular_Medicine_and_Medical_Biotechnology_long_version_.pdf Download (2MB) | Anteprima |
Tipologia del documento: | Tesi di dottorato |
---|---|
Lingua: | English |
Titolo: | Selection of aptamers targeting a hypoxia marker: Carbonic Anhydrase-IX (CA-IX) |
Autori: | Autore Email Nuzzo, Silvia nuzzo.silvia@gmail.com |
Data: | 2018 |
Numero di pagine: | 94 |
Istituzione: | Università degli Studi di Napoli Federico II |
Dipartimento: | dep14 |
Dottorato: | phd054 |
Ciclo di dottorato: | 30 |
Coordinatore del Corso di dottorato: | nome email Avvedimento, Vittorio Enrico vittorioenrico.avvedimento@unina.it |
Tutor: | nome email de Franciscis, Vittorio [non definito] |
Data: | 2018 |
Numero di pagine: | 94 |
Parole chiave: | aptamers, hypoxia |
Settori scientifico-disciplinari del MIUR: | Area 06 - Scienze mediche > MED/04 - Patologia generale |
Depositato il: | 27 Dic 2017 23:52 |
Ultima modifica: | 25 Lug 2020 01:00 |
URI: | http://www.fedoa.unina.it/id/eprint/12248 |
Abstract
Aptamers are selected by an in vitro combinatorial chemistry approach, named Systematic Evolution of Ligands by Exponential enrichment (SELEX), and they are able to bind with high affinity and specificity virtually any given molecule. Compared to monoclonal antibodies, they have a small size that results in their rapid tumour penetration; they are not immunogenic and could be easily modified to increase their in vivo stability. Thus, in this study we describe the selection of RNA-based aptamers directed against an hypoxic biomarker. Firstly, we performed two different cell-based SELEX protocols that allowed the specific enrichment for the target. Furthermore, we characterized and improved the two best sequences selected, named S-47s1 and S-51s1, that we are still studying to handle a final product usable for diagnostic and therapeutic purposes.
Downloads
Downloads per month over past year
Actions (login required)
![]() |
Modifica documento |